PDL BIOPHARMA INC - NOTE 2.750%12/0

CUSIP: 69329YAG9

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Debt / NOTE 2.750%12/0
Market price (% of par)
105.08%
Total 13F principal
$135,457,008
Principal change
+$1,229,071
Total reported market value
$157,195,011
Number of holders
20
Value change
+$1,224,555
Number of buys
7
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 69329YAG9?
CUSIP 69329YAG9 identifies 69329YAG9 - PDL BIOPHARMA INC - NOTE 2.750%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PDL BIOPHARMA INC - NOTE 2.750%12/0 as of Q2 2019

As of 30 Jun 2019, PDL BIOPHARMA INC - NOTE 2.750%12/0 was held by 20 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $135,457,008 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, LAZARD ASSET MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, Linden Advisors LP, DEUTSCHE BANK AG\, Whitebox Advisors LLC, SMH CAPITAL ADVISORS INC, Context Capital Management, LLC, WELLS FARGO & COMPANY/MN, and Pinnacle Holdings, LLC. This page lists 20 institutional bondholders reporting positions for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.